|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
« Previous
Saturday, July 25
by
All About MS
on Sat 25 Jul 2009 12:00 AM CST
Natalizumab is an antibody directed against integrin alpha4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the Central Nervouse System (CNS). The goal of this study was more »
Friday, July 10
by
All About MS
on Fri 10 Jul 2009 04:30 PM CST
Over the two-year period of the study, 80% of the low dose regimen Cladribine arm and 79% of the high-dose regimen arm experienced no clinical relapse, compared with 61% of the more »
by
All About MS
on Fri 10 Jul 2009 04:18 PM CST
Over 11 million women in the United States suffer from stress urinary incontinence (SUI), the involuntary leakage of urine during routine physical activities such as laughing, coughing, exercising, or sneezing. SUI affects women more »
Monday, July 6
by
All About MS
on Mon 06 Jul 2009 12:00 AM CST
Two of the most popular and promising dietary supplements -- vitamin D and fish oil -- will be tested in a large, government-sponsored study to see whether either nutrient can lower a healthy person's risk of getting cancer more »
Sunday, July 5
by
All About MS
on Sun 05 Jul 2009 11:02 AM CST
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced completion of patient enrollment for the second pivotal Phase III clinical trial, BRAVO, evaluating the novel, oral once-daily immunomodulating more »
Saturday, July 4
by
All About MS
on Sat 04 Jul 2009 12:00 AM CST
This research study will evaluate a treatment for moderate to severe spasticity associated with MS. All patients must have been on baclofen for at least four weeks prior to first visit. This study requires more »
Friday, July 3
by
All About MS
on Fri 03 Jul 2009 10:53 AM CST
Discomfort or pain in your legs which worsens at night or when resting
A strong urge to move your legs for relief
Itching, pulling, creepy-crawly, tugging, or gnawing more »
|
||